Cymbalta significantly reduces pain in study patients

08/25/2008 | Wall Street Journal, The · Indianapolis Business Journal

Eli Lilly and Co. reported that 31% of 236 patients showed a 50% reduction in chronic lower-back pain after taking once-daily doses of Cymbalta in a study of the depression drug. Only 19% of patients who got placebo reported the same effect, according to the study. The company, which presented the data during a conference in Spain, is seeking FDA approval to market Cymbalta for treating chronic pain.

View Full Article in:

Wall Street Journal, The · Indianapolis Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA